毛细管电泳市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球毛细管电泳市场价值为 3.672 亿美元，预计到 2034 年将以 5.6% 的复合年增长率增长，达到 6.331 亿美元。随着医疗保健产业转向更准确、个人化和数据驱动的治疗方法，对毛细管电泳等高效分析工具的需求正在上升。该技术因其能够根据大小和电荷分离小分子或离子的高精度而越来越受到人们的重视，这使其在基因分析、疾病诊断和药物研究中非常有效。随着基因组学、蛋白质组学和法医学中应用的不断增长，毛细管电泳法继续受到学术、临床和工业研究领域的关注。

研究人员和临床医生越来越依赖这种方法来检测基因突变、监测病原体和分析复杂的生物混合物，这有助于他们制定更有针对性的治疗方法并改善患者的整体治疗效果。由于研发投资的增加、对先进诊断方法的监管支持以及该技术与下一代测序工作流程的快速集成，市场也见证了强劲的发展势头。随着全球对精准医疗的需求不断增长，毛细管电泳正成为分子诊断工具包中不可或缺的一部分。

市场分为仪器、消耗品和软体。其中，消耗品占了相当大的份额，2024 年创造了 2.165 亿美元的市场规模，预计到 2034 年将以 5.4% 的复合年增长率成长。毛细管和专用试剂等消耗品对于维持技术的完整性和性能至关重要。由于实验室严重依赖一致的高品质耗材来确保准确的结果，这一领域在常规需求的推动下继续保持稳定成长。

根据类型，毛细管凝胶电泳 (CGE) 部分在 2024 年占据了 45.7% 的市场份额。 CGE 广泛用于分离 DNA、RNA 和蛋白质等大型生物分子，使其成为基因定序、突变分析和蛋白质体学的首选技术。它能够提供高度准确的结果，这使得它对于需要分离复杂生物化合物的研究和诊断应用来说不可或缺。

美国毛细管电泳市场正在迅速扩张，这得益于对早期疾病检测（尤其是肿瘤学）的需求不断增长。该技术可以对与癌症相关的遗传标记进行高解析度分析，从而促进个人化治疗计划的发展。领先研究机构的持续创新正在提高该技术的精确度，特别是在生物标记识别方面。

包括赛默飞世尔科技、凯杰公司、Bio-Techne 和安捷伦科技在内的领导企业都致力于推动其产品组合。这些公司正在提高仪器灵敏度、改善耗材性能，并寻求合作推出满足日益增长的个人化医疗解决方案需求的整合系统。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 传染病发生率不断上升
    • 扩大製药和生物技术产业的应用
    • 遗传和分子研究需求不断增长
    • 毛细管电泳技术进步
  • 产业陷阱与挑战
    • 初期投资及维护成本高
    • 新兴国家高素质专业人才有限
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 仪器
  • 全自动毛细管电泳系统
  • 半自动毛细管电泳系统
• 耗材
• 软体

第六章：市场估计与预测：按类型，2021 - 2034 年

• 主要趋势
• 毛细管区带电泳（CZE）
• 胶束电动毛细管层析法（MEKC）
• 毛细管电色谱法（CEC）
• 毛细管等电聚焦（CIEF）
• 毛细管等速电泳（CITP）
• 毛细管凝胶电泳（CGE）

第七章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 核酸分析
• 蛋白质分析
• 基因组DNA
• 质粒DNA
• 片段分析
• RNA/mRNA分析
• 其他应用

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 製药和生物技术公司
• 学术和研究组织
• 临床实验室
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第十章：公司简介

• Agilent Technologies
• Bio-Rad Laboratories
• Bio-Techne
• Danaher Corporation
• Helena Laboratories Corporation
• Lumex Instruments
• Merck
• Prince Technologies
• QIAGEN
• Thermo Fisher Scientific

The Global Capillary Electrophoresis Market was valued at USD 367.2 million in 2024 and is estimated to grow at a CAGR of 5.6% to reach USD 633.1 million by 2034. As the healthcare industry shifts toward more accurate, personalized, and data-driven treatment approaches, the demand for efficient analytical tools like capillary electrophoresis is on the rise. This technology is gaining ground due to its high precision in separating small molecules or ions based on size and charge, which makes it exceptionally effective for genetic analysis, disease diagnostics, and pharmaceutical research. With growing applications in genomics, proteomics, and forensic science, capillary electrophoresis continues to attract attention across academic, clinical, and industrial research landscapes.

Researchers and clinicians are increasingly leaning on this method to detect genetic mutations, monitor pathogens, and analyze complex biological mixtures, which is helping them formulate better-targeted therapies and improve overall patient outcomes. The market is also witnessing strong momentum due to rising investments in R&D, regulatory support for advanced diagnostic methods, and the rapid integration of this technology into next-generation sequencing workflows. As global demand for precision medicine grows, capillary electrophoresis is emerging as an indispensable part of the molecular diagnostics toolkit.

The market is segmented into instruments, consumables, and software. Among these, consumables held a significant share, generating USD 216.5 million in 2024, and are expected to expand at a CAGR of 5.4% through 2034. Consumables such as capillaries and specialized reagents are critical to maintaining the integrity and performance of the technique. With laboratories relying heavily on consistent, high-quality consumables to ensure accurate results, this segment continues to see steady growth driven by routine demand.

Based on type, the capillary gel electrophoresis (CGE) segment accounted for a 45.7% market share in 2024. CGE is widely used to separate large biomolecules like DNA, RNA, and proteins, making it a go-to technique for genetic sequencing, mutation analysis, and proteomics. Its ability to deliver highly accurate results makes it indispensable for research and diagnostic applications that require the separation of complex biological compounds.

The U.S. Capillary Electrophoresis Market is expanding rapidly, driven by rising demand for early disease detection, especially in oncology. The technique enables high-resolution analysis of genetic markers linked to cancer, facilitating the development of personalized treatment plans. Ongoing innovations from leading research institutions are enhancing the technique's precision, particularly in biomarker identification.

Leading players, including Thermo Fisher Scientific, QIAGEN, Bio-Techne, and Agilent Technologies, are focused on advancing their product portfolios. These companies are enhancing instrument sensitivity, improving consumable performance, and pursuing collaborations to introduce integrated systems that align with the growing need for personalized healthcare solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidences of infectious disease
    • 3.2.1.2 Expanding applications in pharmaceutical and biotech industries
    • 3.2.1.3 Rising demand for genetic and molecular research
    • 3.2.1.4 Technological advancement in capillary electrophoresis
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High initial investment and maintenance costs
    • 3.2.2.2 Limited availability of highly trained professionals in emerging countries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
  • 5.2.1 Automatic capillary electrophoresis systems
  • 5.2.2 Semi-automatic capillary electrophoresis systems
• 5.3 Consumables
• 5.4 Software

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Capillary zone electrophoresis (CZE)
• 6.3 Micellar electrokinetic capillary chromatography (MEKC)
• 6.4 Capillary electrochromatography (CEC)
• 6.5 Capillary isoelectric focusing (CIEF)
• 6.6 Capillary isotachophoresis (CITP)
• 6.7 Capillary gel electrophoresis (CGE)

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Nucleic acid analysis
• 7.3 Protein analysis
• 7.4 Genomic DNA
• 7.5 Plasmid DNA
• 7.6 Fragment analysis
• 7.7 RNA/mRNA analysis
• 7.8 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical and biotechnology companies
• 8.3 Academic and research organizations
• 8.4 Clinical laboratories
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Agilent Technologies
• 10.2 Bio-Rad Laboratories
• 10.3 Bio-Techne
• 10.4 Danaher Corporation
• 10.5 Helena Laboratories Corporation
• 10.6 Lumex Instruments
• 10.7 Merck
• 10.8 Prince Technologies
• 10.9 QIAGEN
• 10.10 Thermo Fisher Scientific